Andrew Davenport is Head of Product Management for ARMR Sciences, Inc. He is responsible for implementing program guidance while organizing development operations. Andrew’s background includes a mix of large and small molecule manufacturing and program management across immunology, oncology, and rare disease indications. He served a Sr. Project Manager and Launch Manager at AstraZeneca, leading teams through successful BLA’s for Saphnelo™, Tezespire™, and the launch of the Beyfortus™ RSV vaccine. Andrew graduated from Boston University with an MBA and helped advise start-ups in the biotech space from academic labs, engaged in novel device implementations alongside bioinformatic implementations.